Clinical trial registry record

FX-322 in Adults With Age-Related Sensorineural Hearing Loss

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 1 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated May 25, 2022.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT04601909
Last registry update
May 25, 2022
Status
Completed
Phase
Phase 1
Sponsor
Frequency Therapeutics
Enrollment
30
Countries
United States
Match confidence
70%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 1
Study design
RANDOMIZED · PARALLEL · TREATMENT · QUADRUPLE
Evidence population
Human clinical study registration
Participants
30
Population
ALL · 66 Years to 85 Years
Duration
2020-09-17 to 2022-05-16
Intervention
FX-322; placebo
Comparator
FX-322; Placebo
Outcomes measured
Systemic Safety: Number of patients with treatment-related adverse events — 3 months; Local Safety: Number of patients with abnormal changes from baseline in otoscopic examinations — 3 months; Local Safety: The number of patients with abnormal changes from baseline in tympanometry — 3 months; Columbia-Suicide Severity Rating Scale (C-SSRS) — 3 months; Audiologic Response Endpoints: Speech Intelligibility - Word Recognition in Quiet (WR) — 3 months; Audiologic Response Endpoints: Speech Intelligibility - Words-In-Noise (WIN) — 3 months; Standard Pure Tone Audiometry — 3 months; Extended High Frequency Pure Tone Audiometry — 3 months; Tinnitus Assessment — 3 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 1A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 70% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Hearing ageing · 70%Source terminology contains: presbycusis. Title supplies longevity context: age-related. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

hearing aging
Open primary sourceExport JSON